During the past decade, Ospedale Civile conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Gruppo di Ricerca GISSI" with 2 trials sponsored, "MicroPort CRM" with 2 trials sponsored, "Avinger, Inc." with 1 trials sponsored and "Azienda Sanitaria ULSS 13 Dolo, Mirano" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile" #1 collaborator was "BUPA Foundation" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile" are "Coronary Artery Disease" (4 trials), "Acute Coronary Syndrome" (2 trials), "Coronary Disease" (2 trials), "Coronary Restenosis" (2 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Ospedale Civile" in a lesser frequency.

Most popular intervention types in "Ospedale Civile" are "Device" (9 trials), "Drug" (5 trials), "Procedure" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "CEA, CAS" (1 trials) and "CTO crossing in femoropopliteal arteries CONNECT II" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Civile". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Ospedale Civile, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".